Company intelligence / Profile preview

BVI Medical

Sarasota, Florida, United Statesbvimedical.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

BVI Medical has a broad commercial portfolio of surgical devices for ophthalmology. Its latest innovation—Leos™ Laser Endoscopy Ophthalmic System—received FDA 510(k) clearance in April 2025 for minimally invasive glaucoma surgery. Leos™ demonstrated safety and efficacy in a randomized controlled clinical trial and will be commercially launched in the US in 2025

Therapeutic areas
Ophthalmology
Modalities
Device
Industry
Surgical Medical Devices
02

Partnerships

Not specified; distributes through global network

Beyond the preview

Go deeper on BVI Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BVI Medical.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call